Galapagos NV (GXEA) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.025x

Based on the latest financial reports, Galapagos NV (GXEA) has a cash flow conversion efficiency ratio of -0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-82.75 Million ≈ $-96.74 Million USD) by net assets (€3.25 Billion ≈ $3.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Galapagos NV's balance sheet to measure how much of total assets are equity-financed.

Galapagos NV - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Galapagos NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GXEA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Galapagos NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Galapagos NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Akzo Nobel India Limited NSE:AKZOINDIA	-0.079x
Kirloskar Brothers Limited NSE:KIRLOSBROS	0.048x
Skywater Technology Inc NASDAQ:SKYT	0.149x
Welspun Living Limited NSE:WELSPUNLIV	N/A
Alkami Technology Inc NASDAQ:ALKT	-0.013x
Kelington Group Bhd KLSE:0151	-0.065x
Nanhua Futures Co Ltd SHG:603093	2.795x
Guangdong Baolihua New Energy Stock Co LTD SHE:000690	0.014x

Annual Cash Flow Conversion Efficiency for Galapagos NV (2016–2025)

The table below shows the annual cash flow conversion efficiency of Galapagos NV from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Galapagos NV.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€3.24 Billion ≈ $3.78 Billion	€-257.46 Million ≈ $-300.99 Million	-0.080x	+27.98%
2024-12-31	€2.90 Billion ≈ $3.39 Billion	€-320.03 Million ≈ $-374.14 Million	-0.110x	+40.49%
2023-12-31	€2.80 Billion ≈ $3.27 Billion	€-518.97 Million ≈ $-606.73 Million	-0.186x	+6.32%
2022-12-31	€2.53 Billion ≈ $2.95 Billion	€-500.54 Million ≈ $-585.19 Million	-0.198x	-3.96%
2021-12-31	€2.64 Billion ≈ $3.09 Billion	€-503.83 Million ≈ $-589.03 Million	-0.191x	-19.10%
2020-12-31	€2.67 Billion ≈ $3.12 Billion	€-427.34 Million ≈ $-499.60 Million	-0.160x	-114.34%
2019-12-31	€2.88 Billion ≈ $3.36 Billion	€3.21 Billion ≈ $3.75 Billion	1.116x	+1050.99%
2018-12-31	€1.21 Billion ≈ $1.42 Billion	€-142.47 Million ≈ $-166.56 Million	-0.117x	+19.24%
2017-12-31	€1.01 Billion ≈ $1.18 Billion	€-147.03 Million ≈ $-171.89 Million	-0.145x	-146.04%
2016-12-31	€758.70 Million ≈ $887.00 Million	€239.40 Million ≈ $279.89 Million	0.316x	--

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$1.82 Billion

€1.56 Billion EUR

Market Cap Rank

#6889 Global

#995 in Germany

Share Price

€23.60

Change (1 day)

-1.67%

52-Week Range

€23.00 - €31.40

All Time High

€246.00